{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T00:48:29Z","timestamp":1787359709835,"version":"build-2736575974"},"reference-count":62,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,7]],"date-time":"2025-07-07T00:00:00Z","timestamp":1751846400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003186","name":"Fredrik och Ingrid Thurings Stiftelse","doi-asserted-by":"publisher","award":["2020-00596"],"award-info":[{"award-number":["2020-00596"]}],"id":[{"id":"10.13039\/501100003186","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020-0146"],"award-info":[{"award-number":["2020-0146"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011747","name":"Novo Nordisk Foundation Center for Basic Metabolic Research","doi-asserted-by":"publisher","award":["NNF20OC0063485"],"award-info":[{"award-number":["NNF20OC0063485"]}],"id":[{"id":"10.13039\/501100011747","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002794","name":"Cancerfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002794","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005753","name":"Kungliga Fysiografiska S\u00e4llskapet i Lund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004722","name":"Stiftelsen Lars Hiertas Minne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004722","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016290","name":"Insamlingsstiftelsen Cancer- och Allergifonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Stiftelsen f\u00f6r\u00a0Strategisk Forskning","doi-asserted-by":"publisher","award":["IRC15-0067"],"award-info":[{"award-number":["IRC15-0067"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Pancreatic ductal adenocarcinoma (PDAC) is a lethal cancer lacking effective drugs and therefore new treatment targets are needed. In this study, we define the role of homeobox protein B6 (HOXB6)\u00a0and HOXB8 in controlling pancreatic cancer tumorigenesis and immune response. Transcriptomic analysis comparing human embryonic and PDAC tissue identified a large overlap of expression profiles suggesting a re-initiation of developmental programs in pancreatic cancer. Specifically, we identified the transcription factors HOXB6 and HOXB8 as potential regulators in PDAC. We described their functions in pancreatic cancer by performing transcriptomic and tumor tissue microarray analyses, in vitro assays in pancreatic and lung cancer cell lines and co-culture experiments with immune cells. Loss of <jats:italic>HOXB6<\/jats:italic> and <jats:italic>HOXB8<\/jats:italic> in pancreatic cancer cells inhibited cell proliferation, induced apoptosis and senescence and enhanced gemcitabine sensitivity. Moreover, reduced <jats:italic>HOXB6<\/jats:italic> and <jats:italic>HOXB8<\/jats:italic> expression in pancreatic and lung adenocarcinoma cell lines affected transcription of immune response pathways which resulted in an increased sensitivity of cancer cells to anti-tumorigenic activities of macrophages suggesting that the <jats:italic>HOXB6<\/jats:italic> and <jats:italic>HOXB8<\/jats:italic> immune regulatory function is conserved in different cancer types. Additionally, na\u00efve M0 macrophages exposed to <jats:italic>HOXB8<\/jats:italic> deficient PDAC cells were unable to differentiate into tumor-associated macrophages, suggesting that <jats:italic>HOXB8<\/jats:italic> promotes the transition of initial anti-tumor macrophage to a tumor-promoting macrophage phenotype in pancreatic cancer. Our findings indicate that <jats:italic>HOXB6<\/jats:italic> and <jats:italic>HOXB8<\/jats:italic> play important roles in regulating cell proliferation, immune response, and treatment resistance to promote pancreatic cancer tumorigenesis and could be useful therapeutic targets.<\/jats:p>","DOI":"10.1186\/s43556-025-00292-5","type":"journal-article","created":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T23:02:19Z","timestamp":1751842939000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Homeobox protein B6 and homeobox protein B8 control immune-cancer cell interactions in pancreatic cancer"],"prefix":"10.1186","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1294-3244","authenticated-orcid":false,"given":"Ludivine","family":"Bertonnier-Brouty","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Bsharat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kavya","family":"Achanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5283-6876","authenticated-orcid":false,"given":"Jonas","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thanya","family":"Pranomphon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0377-9975","authenticated-orcid":false,"given":"Tuomas","family":"Kaprio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6079-7881","authenticated-orcid":false,"given":"Jaana","family":"Hagstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0456-4965","authenticated-orcid":false,"given":"Caj","family":"Haglund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"Sepp\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4400-6741","authenticated-orcid":false,"given":"Rashmi B.","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2895-5664","authenticated-orcid":false,"given":"Isabella","family":"Artner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,7]]},"reference":[{"issue":"1","key":"292_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nrdp.2016.22","volume":"2","author":"J Kleeff","year":"2016","unstructured":"Kleeff J, Korc M, Apte M, La Vecchia C, Johnson CD, Biankin AV, et al. Pancreatic cancer. Nat Rev Dis Primers. 2016;2(1):1\u201322. https:\/\/doi.org\/10.1038\/nrdp.2016.22.","journal-title":"Nat Rev Dis Primers"},{"issue":"11","key":"292_CR2","doi-asserted-by":"publisher","first-page":"e72816","DOI":"10.7759\/cureus.72816","volume":"16","author":"R Qadir","year":"2024","unstructured":"Qadir R, Umair MB, Tariq UB, Ahmad A, Kiran W, Shahid MH. Unraveling pancreatic cancer: epidemiology, risk factors, and global trends. Cureus. 2024;16(11):e72816. https:\/\/doi.org\/10.7759\/cureus.72816.","journal-title":"Cureus"},{"issue":"5","key":"292_CR3","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1053\/j.gastro.2023.02.012","volume":"164","author":"EM Stoffel","year":"2023","unstructured":"Stoffel EM, Brand RE, Goggins M. Pancreatic cancer: changing epidemiology and new approaches to risk assessment, early detection, and prevention. Gastroenterology. 2023;164(5):752\u201365. https:\/\/doi.org\/10.1053\/j.gastro.2023.02.012.","journal-title":"Gastroenterology"},{"issue":"27","key":"292_CR4","doi-asserted-by":"publisher","first-page":"4298","DOI":"10.3748\/WJG.V27.I27.4298","volume":"27","author":"JX Hu","year":"2021","unstructured":"Hu JX, Lin YY, Zhao CF, Chen WB, Liu QC, Li QW, et al. Pancreatic cancer: A review of epidemiology, trend, and risk factors. World J Gastroenterol. 2021;27(27):4298. https:\/\/doi.org\/10.3748\/WJG.V27.I27.4298.","journal-title":"World J Gastroenterol"},{"issue":"9","key":"292_CR5","doi-asserted-by":"publisher","first-page":"2649","DOI":"10.1002\/cam4.767","volume":"5","author":"AS Quante","year":"2016","unstructured":"Quante AS, Ming C, Rottmann M, Engel J, Boeck S, Heinemann V, et al. Projections of cancer incidence and cancer-related deaths in Germany by 2020 and 2030. Cancer Med. 2016;5(9):2649\u201356. https:\/\/doi.org\/10.1002\/cam4.767.","journal-title":"Cancer Med"},{"issue":"11","key":"292_CR6","doi-asserted-by":"publisher","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","volume":"74","author":"L Rahib","year":"2014","unstructured":"Rahib L, Smith BD, Aizenberg R, Rosenzweig AB, Fleshman JM, Matrisian LM. Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the united states. Can Res. 2014;74(11):2913\u201321. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-0155.","journal-title":"Can Res"},{"key":"292_CR7","doi-asserted-by":"publisher","unstructured":"Geyer M, Gaul LM, SL DA, Corbo V, Queiroz K. The tumor stroma influences immune cell distribution and recruitment in a PDAC-on-a-chip model. Front Immunol. 2023;14:1155085. https:\/\/doi.org\/10.3389\/fimmu.2023.1155085.","DOI":"10.3389\/fimmu.2023.1155085"},{"issue":"4","key":"292_CR8","doi-asserted-by":"publisher","first-page":"688","DOI":"10.20892\/j.issn.2095-3941.2019.0252","volume":"16","author":"F Quinonero","year":"2019","unstructured":"Quinonero F, Mesas C, Doello K, Cabeza L, Perazzoli G, Jimenez-Luna C, et al. The challenge of drug resistance in pancreatic ductal adenocarcinoma: a current overview. Cancer Biol Med. 2019;16(4):688\u201399. https:\/\/doi.org\/10.20892\/j.issn.2095-3941.2019.0252.","journal-title":"Cancer Biol Med"},{"issue":"7592","key":"292_CR9","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1038\/nature16965","volume":"531","author":"P Bailey","year":"2016","unstructured":"Bailey P, Chang DK, Nones K, Johns AL, Patch AM, Gingras MC, et al. Genomic analyses identify molecular subtypes of pancreatic cancer. Nature. 2016;531(7592):47\u201352. https:\/\/doi.org\/10.1038\/nature16965.","journal-title":"Nature"},{"issue":"2","key":"292_CR10","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.pan.2017.12.013","volume":"18","author":"AAT Naqvi","year":"2018","unstructured":"Naqvi AAT, Hasan GM, Hassan MI. Investigating the role of transcription factors of pancreas development in pancreatic cancer. Pancreatology. 2018;18(2):184\u201390. https:\/\/doi.org\/10.1016\/j.pan.2017.12.013.","journal-title":"Pancreatology"},{"issue":"25","key":"292_CR11","doi-asserted-by":"publisher","first-page":"10500","DOI":"10.1073\/pnas.0704054104","volume":"104","author":"FC Lynn","year":"2007","unstructured":"Lynn FC, Smith SB, Wilson ME, Yang KY, Nekrep N, German MS. Sox9 coordinates a transcriptional network in pancreatic progenitor cells. Proc Natl Acad Sci U S A. 2007;104(25):10500\u20135. https:\/\/doi.org\/10.1073\/pnas.0704054104.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"292_CR12","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1900\/RDS.2014.11.51","volume":"11","author":"PA Seymour","year":"2014","unstructured":"Seymour PA. Sox9: a master regulator of the pancreatic program. Rev Diabet Stud. 2014;11(1):51\u201383. https:\/\/doi.org\/10.1900\/RDS.2014.11.51.","journal-title":"Rev Diabet Stud"},{"key":"292_CR13","doi-asserted-by":"publisher","unstructured":"Kopantzev E, Kondratyeva L, Kopantseva M, Kashkin K, Gnatenko D, Grigorieva E et al. SOX9 Protein in Pancreatic Cancer Regulates Multiple Cellular Networks in a Cell-Specific Manner. Biomedicines. 2022;10(7). https:\/\/doi.org\/10.3390\/biomedicines10071466.","DOI":"10.3390\/biomedicines10071466"},{"issue":"1","key":"292_CR14","doi-asserted-by":"publisher","first-page":"5354","DOI":"10.1038\/s41467-023-40893-8","volume":"14","author":"Z Ma","year":"2023","unstructured":"Ma Z, Zhang X, Zhong W, Yi H, Chen X, Zhao Y, et al. Deciphering early human pancreas development at the single-cell level. Nat Commun. 2023;14(1):5354. https:\/\/doi.org\/10.1038\/s41467-023-40893-8.","journal-title":"Nat Commun"},{"key":"292_CR15","doi-asserted-by":"publisher","first-page":"770428","DOI":"10.3389\/fonc.2021.770428","volume":"11","author":"Y Feng","year":"2021","unstructured":"Feng Y, Zhang T, Wang Y, Xie M, Ji X, Luo X, et al. Homeobox genes in cancers: from carcinogenesis to recent therapeutic intervention. Front Oncol. 2021;11:770428. https:\/\/doi.org\/10.3389\/fonc.2021.770428.","journal-title":"Front Oncol"},{"key":"292_CR16","doi-asserted-by":"publisher","first-page":"273","DOI":"10.2147\/CMAR.S185205","volume":"11","author":"X Yan","year":"2019","unstructured":"Yan X, Wan H, Hao X, Lan T, Li W, Xu L, et al. Importance of gene expression signatures in pancreatic cancer prognosis and the establishment of a prediction model. Cancer Manag Res. 2019;11:273\u201383. https:\/\/doi.org\/10.2147\/CMAR.S185205.","journal-title":"Cancer Manag Res"},{"issue":"26","key":"292_CR17","doi-asserted-by":"publisher","first-page":"42537","DOI":"10.18632\/oncotarget.16451","volume":"8","author":"Y Mao","year":"2017","unstructured":"Mao Y, Shen J, Lu Y, Lin K, Wang H, Li Y, et al. RNA sequencing analyses reveal novel differentially expressed genes and pathways in pancreatic cancer. Oncotarget. 2017;8(26):42537\u201347. https:\/\/doi.org\/10.18632\/oncotarget.16451.","journal-title":"Oncotarget"},{"issue":"3","key":"292_CR18","first-page":"1551","volume":"8","author":"D Yang","year":"2016","unstructured":"Yang D, Yan R, Zhang X, Zhu Z, Wang C, Liang C. Deregulation of microRNA-375 inhibits cancer proliferation migration and chemosensitivity in pancreatic cancer through the association of HOXB3. Am J Transl Res. 2016;8(3):1551\u20139.","journal-title":"Am J Transl Res"},{"key":"292_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1186\/1471-2407-13-451","volume":"13","author":"T Chile","year":"2013","unstructured":"Chile T, Fortes MA, Correa-Giannella ML, Brentani HP, Maria DA, Puga RD, et al. HOXB7 mRNA is overexpressed in pancreatic ductal adenocarcinomas and its knockdown induces cell cycle arrest and apoptosis. BMC Cancer. 2013;13:451. https:\/\/doi.org\/10.1186\/1471-2407-13-451.","journal-title":"BMC Cancer"},{"issue":"7","key":"292_CR20","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1007\/s10620-014-3033-6","volume":"59","author":"XP Cui","year":"2014","unstructured":"Cui XP, Qin CK, Zhang ZH, Su ZX, Liu X, Wang SK, et al. HOXA10 promotes cell invasion and MMP-3 expression via TGF\u03b22-mediated activation of the p38 MAPK pathway in pancreatic cancer cells. Dig Dis Sci. 2014;59(7):1442\u201351. https:\/\/doi.org\/10.1007\/s10620-014-3033-6.","journal-title":"Dig Dis Sci"},{"key":"292_CR21","doi-asserted-by":"publisher","unstructured":"Luo Z, Rhie SK, Farnham PJ. The enigmatic HOX genes: can we crack their code? Cancers (Basel). 2019;11(3). https:\/\/doi.org\/10.3390\/cancers11030323.","DOI":"10.3390\/cancers11030323"},{"issue":"22","key":"292_CR22","doi-asserted-by":"publisher","first-page":"3859","DOI":"10.1242\/dev.126888","volume":"142","author":"BM Larsen","year":"2015","unstructured":"Larsen BM, Hrycaj SM, Newman M, Li Y, Wellik DM. Mesenchymal Hox6 function is required for mouse pancreatic endocrine cell differentiation. Development. 2015;142(22):3859\u201368. https:\/\/doi.org\/10.1242\/dev.126888.","journal-title":"Development"},{"issue":"3","key":"292_CR23","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.jcmgh.2020.05.004","volume":"10","author":"PE Garcia","year":"2020","unstructured":"Garcia PE, Adoumie M, Kim EC, Zhang Y, Scales MK, El-Tawil YS, et al. Differential Contribution of Pancreatic Fibroblast Subsets to the Pancreatic Cancer Stroma. Cell Mol Gastroenterol Hepatol. 2020;10(3):581\u201399. https:\/\/doi.org\/10.1016\/j.jcmgh.2020.05.004.","journal-title":"Cell Mol Gastroenterol Hepatol"},{"issue":"9","key":"292_CR24","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41422-019-0195-y","volume":"29","author":"J Peng","year":"2019","unstructured":"Peng J, Sun B-F, Chen C-Y, Zhou J-Y, Chen Y-S, Chen H, et al. Single-cell RNA-seq highlights intra-tumoral heterogeneity and malignant progression in pancreatic ductal adenocarcinoma. Cell Res. 2019;29(9):725\u201338. https:\/\/doi.org\/10.1038\/s41422-019-0195-y.","journal-title":"Cell Res"},{"key":"292_CR25","doi-asserted-by":"publisher","unstructured":"Bsharat S, Monni E, Singh T, Johansson JK, Achanta K, Bertonnier-Brouty L et al. MafB-dependent neurotransmitter signaling promotes beta cell migration in the developing pancreas. Development. 2023;150(6). https:\/\/doi.org\/10.1242\/dev.201009.","DOI":"10.1242\/dev.201009"},{"issue":"6","key":"292_CR26","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.tcb.2018.02.001","volume":"28","author":"A Hernandez-Segura","year":"2018","unstructured":"Hernandez-Segura A, Nehme J, Demaria M. Hallmarks of Cellular Senescence. Trends Cell Biol. 2018;28(6):436\u201353. https:\/\/doi.org\/10.1016\/j.tcb.2018.02.001.","journal-title":"Trends Cell Biol"},{"issue":"2","key":"292_CR27","doi-asserted-by":"publisher","first-page":"139","DOI":"10.3892\/ol.2020.12400","volume":"21","author":"ZQ Ye","year":"2021","unstructured":"Ye ZQ, Chen HB, Zhang TY, Chen Z, Tian L, Gu DN. MicroRNA-7 modulates cellular senescence to relieve gemcitabine resistance by targeting PARP1\/NF-kappaB signaling in pancreatic cancer cells. Oncol Lett. 2021;21(2):139. https:\/\/doi.org\/10.3892\/ol.2020.12400.","journal-title":"Oncol Lett"},{"issue":"6","key":"292_CR28","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1038\/s41568-022-00450-9","volume":"22","author":"L Wang","year":"2022","unstructured":"Wang L, Lankhorst L, Bernards R. Exploiting senescence for the treatment of cancer. Nat Rev Cancer. 2022;22(6):340\u201355. https:\/\/doi.org\/10.1038\/s41568-022-00450-9.","journal-title":"Nat Rev Cancer"},{"key":"292_CR29","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1016\/j.semcdb.2014.06.005","volume":"34","author":"T Montavon","year":"2014","unstructured":"Montavon T, Soshnikova N. Hox gene regulation and timing in embryogenesis. Semin Cell Dev Biol. 2014;34:76\u201384. https:\/\/doi.org\/10.1016\/j.semcdb.2014.06.005.","journal-title":"Semin Cell Dev Biol"},{"issue":"43","key":"292_CR30","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci U S A. 2005;102(43):15545\u201350. https:\/\/doi.org\/10.1073\/pnas.0506580102.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"6","key":"292_CR31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsdottir H, Ghandi M, Mesirov JP, Tamayo P. The Molecular Signatures Database (MSigDB) hallmark gene set collection. Cell Syst. 2015;1(6):417\u201325. https:\/\/doi.org\/10.1016\/j.cels.2015.12.004.","journal-title":"Cell Syst"},{"issue":"D1","key":"292_CR32","doi-asserted-by":"publisher","first-page":"D687","DOI":"10.1093\/nar\/gkab1028","volume":"50","author":"M Gillespie","year":"2022","unstructured":"Gillespie M, Jassal B, Stephan R, Milacic M, Rothfels K, Senff-Ribeiro A, et al. The reactome pathway knowledgebase 2022. Nucleic Acids Res. 2022;50(D1):D687\u201392. https:\/\/doi.org\/10.1093\/nar\/gkab1028.","journal-title":"Nucleic Acids Res"},{"issue":"D1","key":"292_CR33","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk D, Kirsch R, Koutrouli M, Nastou K, Mehryary F, Hachilif R, et al. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Res. 2023;51(D1):D638\u201346. https:\/\/doi.org\/10.1093\/nar\/gkac1000.","journal-title":"Nucleic Acids Res"},{"issue":"20","key":"292_CR34","doi-asserted-by":"publisher","first-page":"e102161","DOI":"10.15252\/embj.2019102161","volume":"38","author":"M Milan","year":"2019","unstructured":"Milan M, Balestrieri C, Alfarano G, Polletti S, Prosperini E, Spaggiari P, et al. FOXA2 controls the cis-regulatory networks of pancreatic cancer cells in a differentiation grade-specific manner. EMBO J. 2019;38(20):e102161. https:\/\/doi.org\/10.15252\/embj.2019102161.","journal-title":"EMBO J"},{"issue":"D1","key":"292_CR35","doi-asserted-by":"publisher","first-page":"D100","DOI":"10.1093\/nar\/gky1128","volume":"47","author":"I Yevshin","year":"2019","unstructured":"Yevshin I, Sharipov R, Kolmykov S, Kondrakhin Y, Kolpakov F. GTRD: a database on gene transcription regulation-2019 update. Nucleic Acids Res. 2019;47(D1):D100\u20135. https:\/\/doi.org\/10.1093\/nar\/gky1128.","journal-title":"Nucleic Acids Res"},{"issue":"1","key":"292_CR36","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","volume":"17","author":"B Li","year":"2016","unstructured":"Li B, Severson E, Pignon JC, Zhao H, Li T, Novak J, et al. Comprehensive analyses of tumor immunity: implications for cancer immunotherapy. Genome Biol. 2016;17(1):174. https:\/\/doi.org\/10.1186\/s13059-016-1028-7.","journal-title":"Genome Biol"},{"issue":"21","key":"292_CR37","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","volume":"77","author":"T Li","year":"2017","unstructured":"Li T, Fan J, Wang B, Traugh N, Chen Q, Liu JS, et al. TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017;77(21):e108\u201310. https:\/\/doi.org\/10.1158\/0008-5472.CAN-17-0307.","journal-title":"Cancer Res"},{"issue":"W1","key":"292_CR38","doi-asserted-by":"publisher","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","volume":"48","author":"T Li","year":"2020","unstructured":"Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q, et al. TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020;48(W1):W509\u201314. https:\/\/doi.org\/10.1093\/nar\/gkaa407.","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"292_CR39","doi-asserted-by":"publisher","first-page":"1531","DOI":"10.1016\/j.jcmgh.2021.07.006","volume":"12","author":"SB Kemp","year":"2021","unstructured":"Kemp SB, Pasca di Magliano M, Crawford HC. Myeloid Cell Mediated Immune Suppression in Pancreatic Cancer. Cell Mol Gastroenterol Hepatol. 2021;12(5):1531\u201342. https:\/\/doi.org\/10.1016\/j.jcmgh.2021.07.006.","journal-title":"Cell Mol Gastroenterol Hepatol."},{"issue":"5","key":"292_CR40","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1007\/s00262-014-1527-x","volume":"63","author":"RZ Panni","year":"2014","unstructured":"Panni RZ, Sanford DE, Belt BA, Mitchem JB, Worley LA, Goetz BD, et al. Tumor-induced STAT3 activation in monocytic myeloid-derived suppressor cells enhances stemness and mesenchymal properties in human pancreatic cancer. Cancer Immunol Immunother. 2014;63(5):513\u201328. https:\/\/doi.org\/10.1007\/s00262-014-1527-x.","journal-title":"Cancer Immunol Immunother"},{"key":"292_CR41","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2024.116930","volume":"177","author":"W Zhang","year":"2024","unstructured":"Zhang W, Wang M, Ji C, Liu X, Gu B, Dong T. Macrophage polarization in the tumor microenvironment: Emerging roles and therapeutic potentials. Biomed Pharmacother. 2024;177: 116930. https:\/\/doi.org\/10.1016\/j.biopha.2024.116930.","journal-title":"Biomed Pharmacother"},{"key":"292_CR42","doi-asserted-by":"publisher","unstructured":"Hubert KA, Wellik DM. Hox genes in development and beyond. Development. 2023;150(1). https:\/\/doi.org\/10.1242\/dev.192476.","DOI":"10.1242\/dev.192476"},{"key":"292_CR43","doi-asserted-by":"publisher","unstructured":"Li B, Huang Q, Wei GH. The role of hox transcription factors in cancer predisposition and progression. Cancers. 2019;11(4). https:\/\/doi.org\/10.3390\/cancers11040528.","DOI":"10.3390\/cancers11040528"},{"key":"292_CR44","doi-asserted-by":"publisher","unstructured":"Cui Y, Zhang C, Wang Y, Ma S, Cao W, Guan F. HOXC11 functions as a novel oncogene in human colon adenocarcinoma and kidney renal clear cell carcinoma. Life Sciences. 2020;243. https:\/\/doi.org\/10.1016\/j.lfs.2019.117230.","DOI":"10.1016\/j.lfs.2019.117230"},{"issue":"7","key":"292_CR45","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1245\/s10434-012-2252-3","volume":"19","author":"K Ohuchida","year":"2012","unstructured":"Ohuchida K, Mizumoto K, Lin C, Yamaguchi H, Ohtsuka T, Sato N, et al. MicroRNA-10a is overexpressed in human pancreatic cancer and involved in its invasiveness partially via suppression of the HOXA1 gene. Ann Surg Oncol. 2012;19(7):2394\u2013402. https:\/\/doi.org\/10.1245\/s10434-012-2252-3.","journal-title":"Ann Surg Oncol"},{"key":"292_CR46","doi-asserted-by":"publisher","unstructured":"Weiss FU, Marques IJ, Woltering JM, Vlecken DH, Aghdassi A, Partecke LI et al. Retinoic acid receptor antagonists inhibit miR-10a expression and block metastatic behavior of pancreatic cancer. Gastroenterology. 2009;137(6):2136\u201345 e1\u20137. https:\/\/doi.org\/10.1053\/j.gastro.2009.08.065.","DOI":"10.1053\/j.gastro.2009.08.065"},{"key":"292_CR47","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1186\/s12935-019-1036-2","volume":"19","author":"L Zhang","year":"2019","unstructured":"Zhang L, Wang Y, Zhang L, You G, Li C, Meng B, et al. LINC01006 promotes cell proliferation and metastasis in pancreatic cancer via miR-2682-5p\/HOXB8 axis. Cancer Cell Int. 2019;19:320. https:\/\/doi.org\/10.1186\/s12935-019-1036-2.","journal-title":"Cancer Cell Int"},{"issue":"32","key":"292_CR48","doi-asserted-by":"publisher","first-page":"4872","DOI":"10.2174\/092986711797535182","volume":"18","author":"M Cantile","year":"2011","unstructured":"Cantile M, Franco R, Schiavo G, Procino A, Cindolo L, Botti G, et al. The HOX genes network in uro-genital cancers: mechanisms and potential therapeutic implications. Curr Med Chem. 2011;18(32):4872\u201384. https:\/\/doi.org\/10.2174\/092986711797535182.","journal-title":"Curr Med Chem"},{"issue":"19","key":"292_CR49","doi-asserted-by":"publisher","first-page":"3797","DOI":"10.1007\/s00018-020-03508-9","volume":"77","author":"CS Goncalves","year":"2020","unstructured":"Goncalves CS, Le Boiteux E, Arnaud P, Costa BM. HOX gene cluster (de)regulation in brain: from neurodevelopment to malignant glial tumours. Cell Mol Life Sci. 2020;77(19):3797\u2013821. https:\/\/doi.org\/10.1007\/s00018-020-03508-9.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"292_CR50","doi-asserted-by":"publisher","first-page":"6629","DOI":"10.1007\/s11033-019-05058-1","volume":"46","author":"A Gzil","year":"2019","unstructured":"Gzil A, Zarebska I, Bursiewicz W, Antosik P, Grzanka D, Szylberg L. Markers of pancreatic cancer stem cells and their clinical and therapeutic implications. Mol Biol Rep. 2019;46(6):6629\u201345. https:\/\/doi.org\/10.1007\/s11033-019-05058-1.","journal-title":"Mol Biol Rep"},{"issue":"1","key":"292_CR51","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1038\/s41598-019-57047-w","volume":"10","author":"P Aldaz","year":"2020","unstructured":"Aldaz P, Otaegi-Ugartemendia M, Saenz-Antonanzas A, Garcia-Puga M, Moreno-Valladares M, Flores JM, et al. SOX9 promotes tumor progression through the axis BMI1-p21(CIP). Sci Rep. 2020;10(1):357. https:\/\/doi.org\/10.1038\/s41598-019-57047-w.","journal-title":"Sci Rep"},{"issue":"19","key":"292_CR52","doi-asserted-by":"publisher","first-page":"5530","DOI":"10.1111\/febs.15637","volume":"288","author":"L Cardoso Alves","year":"2021","unstructured":"Cardoso Alves L, Corazza N, Micheau O, Krebs P. The multifaceted role of TRAIL signaling in cancer and immunity. FEBS J. 2021;288(19):5530\u201354. https:\/\/doi.org\/10.1111\/febs.15637.","journal-title":"FEBS J"},{"issue":"1","key":"292_CR53","doi-asserted-by":"publisher","first-page":"1788","DOI":"10.1038\/s41598-018-37433-6","volume":"9","author":"C Spano","year":"2019","unstructured":"Spano C, Grisendi G, Golinelli G, Rossignoli F, Prapa M, Bestagno M, et al. Soluble TRAIL Armed Human MSC As Gene Therapy For Pancreatic Cancer. Sci Rep. 2019;9(1):1788. https:\/\/doi.org\/10.1038\/s41598-018-37433-6.","journal-title":"Sci Rep"},{"issue":"1","key":"292_CR54","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1186\/s12885-018-4688-8","volume":"18","author":"JP Gundlach","year":"2018","unstructured":"Gundlach JP, Hauser C, Schlegel FM, Boger C, Roder C, Rocken C, et al. Cytoplasmic TRAIL-R1 is a positive prognostic marker in PDAC. BMC Cancer. 2018;18(1):777. https:\/\/doi.org\/10.1186\/s12885-018-4688-8.","journal-title":"BMC Cancer"},{"issue":"8","key":"292_CR55","doi-asserted-by":"publisher","first-page":"101685","DOI":"10.1016\/j.xcrm.2024.101685","volume":"5","author":"G Grisendi","year":"2024","unstructured":"Grisendi G, Dall\u2019Ora M, Casari G, Spattini G, Farshchian M, Melandri A, et al. Combining gemcitabine and MSC delivering soluble TRAIL to target pancreatic adenocarcinoma and its stroma. Cell Rep Med. 2024;5(8):101685. https:\/\/doi.org\/10.1016\/j.xcrm.2024.101685.","journal-title":"Cell Rep Med"},{"key":"292_CR56","doi-asserted-by":"publisher","first-page":"743908","DOI":"10.3389\/fcell.2021.743908","volume":"9","author":"Z Xu","year":"2021","unstructured":"Xu Z, Hu K, Bailey P, Springfeld C, Roth S, Kurilov R, et al. Clinical impact of molecular subtyping of pancreatic cancer. Front Cell Dev Biol. 2021;9:743908. https:\/\/doi.org\/10.3389\/fcell.2021.743908.","journal-title":"Front Cell Dev Biol"},{"issue":"1","key":"292_CR57","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s43556-024-00196-w","volume":"5","author":"J Yang","year":"2024","unstructured":"Yang J, Li J, Li S, Yang Y, Su H, Guo H, et al. Effects of HOX family regulator-mediated modification patterns and immunity characteristics on tumor-associated cell type in endometrial cancer. Mol Biomed. 2024;5(1):32. https:\/\/doi.org\/10.1186\/s43556-024-00196-w.","journal-title":"Mol Biomed"},{"issue":"9","key":"292_CR58","doi-asserted-by":"publisher","first-page":"e7187","DOI":"10.1002\/cam4.7187","volume":"13","author":"L Bertonnier-Brouty","year":"2024","unstructured":"Bertonnier-Brouty L, Andersson J, Kaprio T, Hagstrom J, Bsharat S, Asplund O, et al. E2F transcription factors promote tumorigenicity in pancreatic ductal adenocarcinoma. Cancer Med. 2024;13(9):e7187. https:\/\/doi.org\/10.1002\/cam4.7187.","journal-title":"Cancer Med"},{"issue":"5","key":"292_CR59","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1002\/ijc.2910150505","volume":"15","author":"M Lieber","year":"1975","unstructured":"Lieber M, Mazzetta J, Nelson-Rees W, Kaplan M, Todaro G. Establishment of a continuous tumor-cell line (panc-1) from a human carcinoma of the exocrine pancreas. Int J Cancer. 1975;15(5):741\u20137. https:\/\/doi.org\/10.1002\/ijc.2910150505.","journal-title":"Int J Cancer"},{"issue":"2","key":"292_CR60","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1002\/ijc.2910260208","volume":"26","author":"S Tsuchiya","year":"1980","unstructured":"Tsuchiya S, Yamabe M, Yamaguchi Y, Kobayashi Y, Konno T, Tada K. Establishment and characterization of a human acute monocytic leukemia cell line (THP-1). Int J Cancer. 1980;26(2):171\u20136. https:\/\/doi.org\/10.1002\/ijc.2910260208.","journal-title":"Int J Cancer"},{"key":"292_CR61","doi-asserted-by":"publisher","unstructured":"Guzm\u00e1n C, Bagga M, Kaur A, Westermarck J, Abankwa D. ColonyArea: an ImageJ plugin to automatically quantify colony formation in clonogenic assays. PloS one. 2014;9(3). https:\/\/doi.org\/10.1371\/journal.pone.0092444.","DOI":"10.1371\/journal.pone.0092444"},{"key":"292_CR62","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/978-1-4939-0888-2_23","volume":"1170","author":"EP Crowe","year":"2014","unstructured":"Crowe EP, Nacarelli T, Bitto A, Lerner C, Sell C, Torres C. Detecting senescence: methods and approaches. Methods Mol Biol. 2014;1170:425\u201345. https:\/\/doi.org\/10.1007\/978-1-4939-0888-2_23.","journal-title":"Methods Mol Biol"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-025-00292-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-025-00292-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,6]],"date-time":"2025-07-06T23:02:21Z","timestamp":1751842941000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-025-00292-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,7]]},"references-count":62,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["292"],"URL":"https:\/\/doi.org\/10.1186\/s43556-025-00292-5","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,7]]},"assertion":[{"value":"3 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 June 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 June 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 July 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical permission has been obtained from the regional ethics committee in Lund (Dnr2012\/593, Dnr 2015\/241, Dnr 2018\u2013579). The Surgical Ethics Committee of HUH approved the study protocol (Dnr. HUH 226\/E6\/06, extension TKM02 \u00a766 17.4.2013). Informed consent was obtained from all subjects involved in the study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All author declared no conflict of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"48"}}